Pennsylvania Department of Health
CHELTENHAM NURSING AND REHABILITATION CENTER
Patient Care Inspection Results

Note: If you need to change the font size, click the "View" menu at the top of the page, place the mouse over the "Text Size" menu item, and select the desired font size.

Severity Designations

Click here for definitions Click here for definitions Click here for definitions Click here for definitions
Minimal Citation - No Harm Minimal Harm Actual Harm Serious Harm
CHELTENHAM NURSING AND REHABILITATION CENTER
Inspection Results For:

There are  220 surveys for this facility. Please select a date to view the survey results.

Surveys don't appear on this website until at least 41 days have elapsed since the exit date of the survey.
CHELTENHAM NURSING AND REHABILITATION CENTER - Inspection Results Scope of Citation
Number of Residents Affected
By Deficient Practice
Initial comments:
Based on an Abbreviated Survey in response to a complaint, completed on April 28, 2025, it was determined that Cheltenham Nursing and Rehabilitation Center, was not in compliance with the following requirements of 42 CFR Part 483, Subpart B, Requirements for Long Term Care Facilities and the 28 PA Code, Commonwealth of Pennsylvania Long Term Care Licensure Regulations, related to the health portion of the survey process.


 Plan of Correction:


483.45(g)(h)(1)(2) REQUIREMENT Label/Store Drugs and Biologicals:This is a less serious (but not lowest level) deficiency and is isolated to the fewest number of residents, staff, or occurrences. This deficiency is one that results in minimal discomfort to the resident or has the potential (not yet realized) to negatively affect the resident's ability to achieve his/her highest functional status.
§483.45(g) Labeling of Drugs and Biologicals
Drugs and biologicals used in the facility must be labeled in accordance with currently accepted professional principles, and include the appropriate accessory and cautionary instructions, and the expiration date when applicable.

§483.45(h) Storage of Drugs and Biologicals

§483.45(h)(1) In accordance with State and Federal laws, the facility must store all drugs and biologicals in locked compartments under proper temperature controls, and permit only authorized personnel to have access to the keys.

§483.45(h)(2) The facility must provide separately locked, permanently affixed compartments for storage of controlled drugs listed in Schedule II of the Comprehensive Drug Abuse Prevention and Control Act of 1976 and other drugs subject to abuse, except when the facility uses single unit package drug distribution systems in which the quantity stored is minimal and a missing dose can be readily detected.
Observations:


Based on observation, staff interview, and clinical record review, it was determined that the facility failed to ensure that a medication label was accurate for one of (Resident R3).

Findings include:

Review of Resident R3's April 2026 physican orders revealed an order dated March 19, 2025, for Potassium Chloride Liquid 20 MEQ/15ML (10%), Give 20 mEq via PEG-Tube one time a day for Hypokalemia (low Potassium Levels)

Observation conducted of the label on the medication for Potassium Chloride revealed Potassium Chloride Liquid 20 MEQ/7.5 ML.

On April 28, 2025, at 10:31 a.m., interview with the Director of Nursing revealed that the Pharmacy wrongly labelled the dose of Potassium Chloride Liquid 20 MEQ/15ML (10%), for R3 as to administer 7.5 ML, instead of 15 ML.

28 Pa. Code 211.9(a)(1) Pharmacy services



 Plan of Correction - To be completed: 05/19/2025

Preparation and/or execution of this plan of correction does not constitute admission or agreement by this provider of the facts alleged, or conclusion set forth in the statement of deficiencies. The plan of correction is prepared and/or executed solely because it is required by the provisions of federal and/or state law. The plan of correction constitutes our credible allegation of compliance.

1. On 4/28/2025 the Nurse Unit Manager immediately assessed Resident R3 and identified no adverse complications related to the medication discrepancy. The physician was notified by the Nurse Unit Manager and orders for follow up labs obtained. Resident's lab results were at a therapeutic level and there were no negative outcomes. The attending Physician changed the order to 7.5 ML. The DON verified that the physician's order matches the label on the medication.
2. On 4/28/2025 the nurse management team reviewed resident's receiving liquid Potassium Chloride to verify that the physician's order in the electronic medical record matched the label on the medication.
3. On 4/28/2025 the DON, ADON and/or designee started education for licensed nursing staff on administering liquid Potassium Chloride based on physicians orders and verifying that medication labels match physician orders in the electronic medical record. Education will be completed by 5/14/2025.
4. During the morning clinical meeting, the IDT team will review all medication changes for liquid Potassium Chloride to verify that order matches the medication label.
5. The DON and/or Designee will conduct random audits on accuracy of medication labels weekly for 4 weeks and monthly for 3 months. The audits will be forwarded to the monthly Quality Assurance Meeting.


Back to County Map


  
Home : Press Releases : Administration
Health Planning and Assessment : Office of the Secretary
Health Promotion and Disease Prevention : Quality Assurance



Copyright © 2001 Commonwealth of Pennsylvania. All Rights Reserved.
Commonwealth of PA Privacy Statement

Visit the PA Power Port